The Ketorolac Tromethamine Injection, cataloged under National Stock Number 6505-01-319-8244, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Syntex Laboratories Inc. Government technical data includes 6 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 3 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 3 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-319-8244 |
| Primary Part Number | NDC00033-2444-40 |
| Item Name | Ketorolac Tromethamine Injection |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Syntex Laboratories Inc |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Content Quantity | 2.000 MILLILITERS |
| Administration | INTRAMUSCULAR |
| Total Primary Container Quantity | 10 |
| Features Provided | STERILE |
| Primary Container Type | SYRINGE-NEEDLE UNIT |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| NDC00033-2444-40 PRIMARY | Syntex Laboratories Inc (USA) |
| TORADOL | Syntex Laboratories Inc (USA) |
| TORADOL INJECTION | Syntex Laboratories Inc (USA) |
NSN 6505-01-319-8244 is a Ketorolac Tromethamine Injection, manufactured by Syntex Laboratories Inc, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-319-8244 has 3 cross-referenced part numbers: NDC00033-2444-40 (Syntex Laboratories Inc), TORADOL (Syntex Laboratories Inc), TORADOL INJECTION (Syntex Laboratories Inc).
There are 3 known substitutes for 6505-01-319-8244: 6505-01-319-8245, 6505-01-504-9523, 6505-01-572-3358. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00033-2444-40: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Content Quantity: 2.000 MILLILITERS; Administration: INTRAMUSCULAR; Total Primary Container Quantity: 10. 7 total characteristics are documented in the Federal Logistics Information System.